Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Muscle loss may slow hip replacement recovery — a trial tests whether exercise can help

NCT ID NCT07734129

Disease control Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Sep 16, 2026 · Updated 3 times

Summary

This trial tests whether screening older adults for sarcopenia (loss of muscle strength and mass) before hip replacement surgery, followed by a structured exercise program after surgery, can improve recovery. Participants aged 65 and older with advanced hip osteoarthritis will be divided into groups: those with sarcopenia who receive the exercise program, those with sarcopenia who receive standard care, and those without sarcopenia who receive standard care. The study aims to see if early detection and targeted rehabilitation can lead to better muscle strength, physical function, and quality of life after hip replacement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a supervised group physical rehabilitation program including stretching, cycling, and strengthening exercises
What this could lead to
If it works, this could point toward a standard approach to identify and treat muscle weakness before and after hip replacement, improving mobility and quality of life for older adults.
What could go wrong
This is a relatively small trial, and the exercise program is short (2 months). Results may not apply to all patients or settings, and adherence to the program could vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects age \>= 65 years of age * Previous diagnosis of advanced hip osteoarthritis. * Patients who are on the surgical waiting list for total joint replacement hip. * Barthel Index \> 80 points. * That they will undergo surgery at the Regional University Hospital of Malaga. Exclusion Criteria: * Patients who refuse to accept and sign the informed consent form surgical intervention. * Patients who refuse to accept and sign the informed consent form participation in the study. * Subjects diagnosed with immunodeficiency or undergoing immunosuppressive treatment. * Subjects diagnosed with inflammatory or hematological disease. * Subjects with coagulation disorders. * Subjects with lung disease, heart disease or unstable high blood pressure. * Subjects diagnosed with neurodegenerative disease that prevents them from performing physical exercise. * Subjects with psychiatric pathology that prevents the performance of physical exercise and adherence to treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coxarthrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

osteoarthritis, hip Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coxarthrosis Sarcopenia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • FIMABIS

    Málaga, 29007, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.